Pharmacokinetic boosting to enable a once-daily reduced dose of tofacitinib in patients with rheumatoid arthritis and psoriatic arthritis (the PRACTICAL study).
Céleste J T van der TogtLise M VerhoefBart J F van den BemtNathan den BroederRob Ter HeineAlfons A den BroederPublished in: Therapeutic advances in musculoskeletal disease (2022)
This study was registered on 29 May 2019 in the Netherlands Trial Register (register number: NL7766).
Keyphrases